NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

Size: px
Start display at page:

Download "NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION"

Transcription

1 NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016

2 Group Overview South Africa United Kingdom Financial Review Guidance

3 GROUP OVERVIEW

4 4 Group A comprehensive network of healthcare services Hospitals Hospital beds Primary healthcare facilities/clinics Retail pharmacies Renal dialysis facilities Netcare 911 emergency bases Netcare training colleges Employees

5 5 Group Overview South Africa (SA) Good demand for services across all divisions Integration of 584 new beds added at end FY 2015 Margin impact of expense inflation, new builds, change in case mix Primary Care focus on expanding day theatre and sub-acute facilities United Kingdom (UK) The private healthcare market has undergone a structural change Private activity growth driven by NHS outsourcing and Self-pay demand NHS-funded patients increased to 41.1% of caseload PMI¹ market remains challenging 1. PMI: Private Medical Insurance

6 6 Group Financial overview 48% Revenue 52% 74% EBITDA 26% 96% HEPS 4% 97% 3% Adjusted HEPS South Africa United Kingdom Revenue R18 814m 15.4% EBITDA R2 663m 13.6% HEPS 90.3 cents 10.9% Adjusted HEPS 91.0 cents 0.2% Interim dividend maintained at 38.0 cents

7 SOUTH AFRICA

8 8 SA Healthcare network 52 Hospitals 5 Public Private Partnership hospitals Beds¹ 90 PHC², sub-acutes, day theatres Renal dialysis stations Emergency bases/sites Retail pharmacies Nursing and paramedic students 1. SA = 9 996; Lesotho = PHC: Primary Healthcare Centres and travel clinics

9 9 SA Financials Rm % Revenue EBITDA Volume and pricing growth impacted by case mix shift in favour of medical admissions Operating profit EBITDA margin (%) Operating profit margin (%) Margin decline in Hospital and Emergency Services and an uplift in Primary Care + Depreciation impact of new capacity added end FY 2015

10 10 SA Hospital and Emergency Services business update 2.8% patient days; 4.0% to April % full week occupancy; 2.2% due to new capacity Polokwane and Pinehaven hospitals occupancies exceeding expectations Shift in mix from surgical to medical at lower income per admission Cost pressures outweighed ongoing efficiency programme benefits Net 117 specialists granted practising privileges

11 11 SA Hospital and Emergency Services Rm % Revenue EBITDA Operating profit EBITDA margin (%) Operating profit margin (%) Note: EBITDA and operating profit are reflected before rental charges from Netcare property companies (eliminate on consolidation) + 2.8% patient days + 5.2% revenue per patient day + Surgical patients contributed 61.5% of admissions (H1 2015: 62.9%) + Rising inflation and currency weakness impacted on cost of sales and operating costs + Two new hospitals in ramp-up phase + Shift in mix to medical cases + Increased depreciation driven by 584 new beds added in late FY 2015

12 QUALITY SYSTEM QUALITY CULTURE 12 SA Quality: sustaining improvement over 5 years Medical outcomes Reduce antibiotic consumption (DDD¹ per 100 bed days) AMI² in-hospital mortality rate per 100 AMI patients discharged % 7.7% Best outcomes Best patient experience TRIPLE AIM Most cost effective Patient safety measures CLABSI³/1000 central line days VAP⁴/1000 ventilator days FY 2016 YTD FY 2011 FY 2016 YTD FY 2011 Patient experience scores Pain management Nursing communication 84.0% 73.9% 85.2% 75.7% FY 2016 YTD FY DDD: Defined Daily Dose (WHO) 2. AMI: Acute Myocardial Infarction 3. CLABSI: Central Line-Associated Bloodstream Infection 4. VAP: Ventilator-Associated Pneumonia

13 13 Netcare Christiaan Barnard Memorial Hospital

14 14 SA Primary Care Rm % Revenue EBITDA Operating profit EBITDA margin (%) Operating profit margin (%) Stable performance across Medicross family medical and dental centres + Solid result at Prime Cure + Refinements to business model and rationalisation of cost base

15 15 SA Primary Care business update Change in strategy to focus on expanding Primary Care s national network of day theatres and sub-acute facilities FY 2016 acquisitions: + 16 bed sub-acute in Pietermaritzburg + 20 bed sub-acute in Amanzimtoti FY 2017/18 growth projects: + 4 new day theatres in Kimberley, Upington, Cape Town and Richards Bay + 3 new sub-acute facilities in Cape Town, Hillcrest and Richards Bay + Further developments in the pipeline

16 16 SA Regulatory update National Health Insurance (NHI) + Government released the NHI White paper in December The proposed NHI changes the way public healthcare is funded + Introduces capacity to contract private sector, starting with private doctors in terms of primary healthcare and emergency services + Contracting of private specialists and hospitals to be considered in later years Private Healthcare Market Inquiry (HMI) + Netcare made comprehensive submissions in 2014, 2015 and Public hearings commenced in 2016; Phase 1 in process + HMI position papers on topics under review still to be published + Final report, which might include recommendations, is still expected at the end of 2016 based on the formal timetable

17 UNITED KINGDOM

18 18 UK BMI Healthcare s hospital network UK s largest private hospital group with 59 sites¹ and beds Offer a broad range of complex healthcare services Widest network of critical care beds in the private sector and 32 cancer units ± consultants and employees 90% of UK PMI policyholders live within 60 minutes of a BMI Healthcare facility Strong commitment to clinical quality and patient satisfaction hospitals, 3 clinics

19 19 UK Market Overall demand for healthcare continues to increase Specific demand funded by private medical cover remains challenging Self-pay demand continues to strengthen as NHS waiting lists grow Sources of funding for private hospitalisation and clinics, UK 2015² ( m) Main driver of private demand growth is NHS outsourcing Outsourcing of NHS activity is being driven by patient choice under AQP¹ policy NHS revenue in private hospitals has increased from 5% to 30% over the last decade Private medical cover UK private Self-pay NHS Overseas 1. AQP: Any Qualified Provider 2. Source: LaingBuisson, 28th edition

20 20 UK Business activity Total NHS Private 2.6% overall activity¹; 3.3% to April % caseload² 3.1% outpatient activity 5.4% caseload; impacted by slow down in Spot purchases 8.5% e-referrals caseload (Choose & Book) 2.9% privately funded caseload 4.6% Self-pay caseload 1. Overall activity: inpatient, day case and outpatient 2. Caseload: inpatient and day cases

21 21 UK Change in payor profile Caseload per payor group 72% H % 41% H % Current caseload per payor group: + NHS 41.1% + Self-pay 11.5% + Insured 47.4% Ongoing migration from inpatient procedures to day case and outpatient procedures NHS Private

22 22 UK Changes at BMI Healthcare Strengthened senior leadership team Clear vision supported by detailed corporate and operational plans Disciplined operating model with a focus on growth, people efficiencies and governance Recruited >300 new consultants >6 700 marketing visits to GPs; >4 000 doctors hosted at education / training events 23 sites successfully inspected under the CQC¹ new inspection regime 1. CQC: Care Quality Commission

23 23 UK BMI Healthcare stakeholder satisfaction trends Overall Quality of Care % Satisfaction with overall quality of care is at its highest % for the last two years having risen to 98.4% up from 98.2% this time last year % Recommendation to Friends and Family % 99% of our NHS patients said they would recommend % BMI Healthcare to their family and friends % Satisfaction with Consultants % 98.9% of patients are very satisfied % with our consultants % Employee Engagement % 95% of staff are fully committed % to doing their very best for BMI Healthcare %

24 24 UK BMI Healthcare m % Revenue (1.4) EBITDA (before items below) (4.4) Restructure costs (6.1) Reversal of impairment 2.0 EBITDA Operating profit Revenue per case impacted by: Payor mix change to NHS Ongoing shift to day and outpatient environment Pressure on NHS tariff + Easter timing impact + GHG PropCo rent 73.9m (2015: 71.8m) + Other rent 5.7m (2015: 7.6m) EBITDA margin (%)¹ Reported EBITDA margin (%) Operating profit margin (%) Excluding restructure costs and reversal of impairment on investments

25 25 UK Capital investment BMI Three Shires New MRI scanner BMI Clementine Churchill New endoscopy suite BMI Clementine Churchill New ICUs BMI Bishops Wood Refurbished cancer care facility

26 FINANCIAL REVIEW

27 27 Group Financial overview Pleasing performance in period of integration of new beds Absorption of depreciation and finance costs on 2015 new capacity Strong group balance sheet Comfortable gearing and leverage

28 28 Group Summarised statement of profit or loss + Growth in SA Rm % + Impact of currency conversion in UK Revenue EBITDA Operating profit Net financial expenses (298) (249) Earnings of associates and JVs Profit before taxation Taxation (426) (452) Profit for the year GHG PropCo rent R1 633m (2015: R1 276m) + Non-recurring costs of UK restructure of R109m in R49m in SA depreciation mostly driven by new capacity + R76m in UK depreciation from weaker Rand + Includes charge of R41m (2015: R107m) non-cash fair value adjustment on RPI swaps + Effective tax rate 25.4% (2015: 27.9%)

29 29 Group Constant currency performance Revenue (Rm) EBITDA (Rm) % % H H H H SA UK Exchange rate impact Average exchange rate of R22.10: 1 (Mar 2015: R17.76: 1) Closing exchange rate of R21.20: 1 (Sept 2015: R20.94: 1)

30 30 Group Headline earnings per share (HEPS) Rm % Adjusted HEPS¹ (cents) HEPS SA UK (3.8) Adjusted HEPS¹ SA UK SA Group H1 H2 1. Adjusted to exclude Competition Commission costs, UK restructure costs, non-cash fair value adjustments on derivative financial instruments and changes in tax rates

31 31 Group Summarised statement of financial position Rm 30 Sep Forex effect Other movement Assets PPE¹, goodwill and intangible assets Other non-current assets Current assets (468) Group capex R1 088m (2015: R747m) + SA: R886m (2015: R531m) + UK: R202m (2015: R216m) Total assets (32) Equity and liabilities Total shareholders equity Borrowings (91) Other liabilities (591) + Group net debt to EBITDA leverage 1.3 times (H1 2015: 1.2 times) + Group interest cover to 10.4 times (H1 2015: 9.6 times) Total equity and liabilities (32) 1. PPE: Property, Plant and Equipment

32 32 Group SA debt Rm Sep Gross debt Cash (1 397) (1 345) (494) Net debt Net debt to EBITDA (times) Facility utilisation (Rm) Cost of debt (%) Net interest paid Interest cover (times) Utilised Cash Available + Cash outlay of R2 207m (2015: R2 026m) for capex, dividends and tax + Comfortable leverage ratio + Capacity of DMTN programme increased to R7.5bn on 1 April % of debt at fixed interest rates

33 33 Group UK debt: BMI Healthcare m Sep Gross debt Cash (38.6) (54.0) (47.4) Facility utilisation ( m) 47.4 Net debt Net debt to EBITDA (times)¹ Cost of debt² Utilised Cash Net interest paid Debt term Comfortable gearing + Fully compliant with debt covenants + Repaid 23.1m maturing debt tranche in October Netcare holds 75.3m economic interest + Cost of debt excluding Netcare economic interest is 4.8% 1. Excluding restructure costs and reversal of impairment on investments 2. Secured bank debt

34 GUIDANCE

35 35 Guidance SA outlook Improvement in occupancy levels as new capacity gains traction Focus on optimising capacity and initiatives to drive operational excellence and quality improvement 85 new hospital beds to be added in H Continue to evaluate potential international opportunities

36 36 Guidance UK outlook Growth in NHS caseload driven by e-referrals NHS tariff increase effective April 2016 BMI Healthcare is well positioned for volume growth and focused on operating efficiencies Capex ± 43m to enhance hospital infrastructure and keep abreast of technological developments

37 THANK YOU May 2016

38 APPENDICES

39 39 Appendix UK income statement segmental analysis m BMI Healthcare GHG PropCo2¹ WholeCo Revenue EBITDA (before GHG PropCo rent and items below) GHG PropCo rent (73.9) (73.9) EBITDA (before items below) Reversal of impairment EBITDA Operating profit Net financial expenses (9.6) (9.6) Equity accounted earnings Profit before taxation Taxation Profit after taxation Comprising 6 hospital properties

40 40 Appendix Group borrowings at ch 2016 Gross borrowings Net borrowings Rm Sep Sep SA BMI OpCo Group Net debt to EBITDA (times) m BMI OpCo Closing exchange rate

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 PRESENTATION OUTLINE Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive

More information

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 1 RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Agenda RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

Netcare Limited Interim results presentation For the six months ended 31 March 2008

Netcare Limited Interim results presentation For the six months ended 31 March 2008 1 Netcare Limited Interim results presentation For the six months ended 31 March 2008 Note regarding forward looking statements The Company advises investors that any forward looking statements or projections

More information

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS for the year ended 30 September 2017 01 contents02 Commentary 10 Declaration of final dividend 12 Group statement of profit or loss 13 Group statement of other comprehensive

More information

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION CARE DIGNITY PARTICIPATION TRUTH PASSION Netcare Limited Audited Group Results for the year ended tember 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION Note regarding forward looking statements The Company

More information

care helping for the health of humankind Netcare Limited 2014

care helping for the health of humankind Netcare Limited 2014 helping care for the health of humankind Netcare Limited 2014 AUDITED GROUP RESULTS for the year ended 30 September 2014 Contents Financial highlights 1 Commentary 2 Declaration of final dividend 9 Group

More information

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 www.lifehealthcare.co.za Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 Operational review André Meyer CEO 2 Highlights Group SA: 3.5%

More information

2018 Half Year Results Presentation. 18 September 2018

2018 Half Year Results Presentation. 18 September 2018 2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including

More information

Financial Year Results Presentation

Financial Year Results Presentation 2016 Financial Year Results Presentation Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare

More information

Investing for the future: Spire

Investing for the future: Spire Investing for the future: Spire Healthcare Aslam Dalvi - Associate Portfolio Manager The UK public healthcare system has come under increasing pressure in recent times. An ageing population coupled with

More information

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018,

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE, FURTHER CAUTIONARY AND TRADING STATEMENT Group LIFE HEALTHCARE UNAUDITED GROUP RESULTS 2018

More information

Spire Healthcare. Interim results for the six months ended 30 June 2018

Spire Healthcare. Interim results for the six months ended 30 June 2018 Spire Healthcare Group plc Spire Healthcare Interim results for the six months ended 30 June 2018 London, UK, 18 September 2017, Spire Healthcare Group plc (LSE: SPI), one of the UK s leading independent

More information

2Q19 Results Presentation. 11 February 2019

2Q19 Results Presentation. 11 February 2019 2Q19 Results Presentation 11 February 2019 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given

More information

FY 2015 Results Presentation. 19 January 2016

FY 2015 Results Presentation. 19 January 2016 FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Interim FY 2015 results 6 months ended 31 December February 2015

Interim FY 2015 results 6 months ended 31 December February 2015 Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights

More information

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer FINANCIAL REVIEW OUR COMMITMENT TO SHAREHOLDER VALUE IS MEASURED USING RETURNS ON INVESTED CAPITAL, THEREBY FOCUSING STRATEGIC DELIBERATIONS ON WAYS TO IMPROVE RETURNS ON THE GROUP S INVESTED ASSET BASE.

More information

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director 5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director AGENDA About Ramsay Health Care The Reason for Ramsay s Success December 07 Half Year Results

More information

Mid Cheshire Hospitals NHS Foundation Trust Annual Members Meeting

Mid Cheshire Hospitals NHS Foundation Trust Annual Members Meeting Mid Cheshire Hospitals NHS Foundation Trust 2016 Annual Members Meeting Welcome and Introductions Dennis Dunn MBE 1 Agenda 1. Welcome and Introductions Dennis Dunn 2. Minutes of the Annual Members meeting

More information

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 GROUP HIGHLIGHTS 5% Revenue 5% PAT 5% HEPS 35.2c 5% Interim dividend declared 11.0 cents per share Slide 2

More information

NETCARE LIMITED 2017

NETCARE LIMITED 2017 NETCARE LIMITED ANNUAL FINANCIAL STATEMENTS 2017 contents ANNUAL FINANCIAL STATEMENTS 02 Directors' responsibility and approval 02 Certificate by the Company Secretary 03 Directors' report 10 Audit Committee

More information

Corporate Performance Report 2015/16

Corporate Performance Report 2015/16 Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close

More information

Highlights of the Group s performance include:

Highlights of the Group s performance include: MEDIA RELEASE 21 November 2017 LIFE HEALTHCARE GROUP POSTS SOLID RESULTS POST ALLIANCE MEDICAL ACQUISITION Johannesburg, 21 November 2017: Life Healthcare Group Holdings Limited (JSE: LHC), one of South

More information

Corporate Performance Report 2013/14

Corporate Performance Report 2013/14 BoD/04/14 Corporate Performance Report 2013/14 December 2013 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier AGENDA 2 Executive Summary Why the UK Hospital Sector? Capio UK Business Overview Transaction Overview Financials Compelling Proposition

More information

Financial and Operational Review

Financial and Operational Review Financial and Operational Review For the year ended 30 June 2018 Colin Goldschmidt CEO, Sonic Healthcare 16 August 2018 Forward-looking statements This presentation may include forward-looking statements

More information

Take control of your business performance

Take control of your business performance Take control of your business performance 16 October 2017 Presented by: Johan Nel Group Financial Manager Cure Day Clinics Knowledge Doubling Curve Introduction Buckminster Fuller created the Knowledge

More information

Barloworld Limited. Reviewed interim results to 31 March May 15, 2006

Barloworld Limited. Reviewed interim results to 31 March May 15, 2006 Barloworld Limited Reviewed interim results to 31 March 2006 May 15, 2006 BARLOWORLD IS A DIVERSIFIED INDUSTRIAL COMPANY Over 26 000 people in 31 countries Barloworld s way of doing business - market-leading

More information

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration Life Healthcare Group Holdings Limited Registration number: 2003/002733/06 Income tax number: 9387/307/15/1 ISIN: ZAE000145892 Share code: LHC Audited Group Results for the year ended 30 September 2013

More information

LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL

LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL SHREY VIRANNA - GROUP CEO PIETER VAN DER WESTHUIZEN - GROUP CFO 27 MARCH 2018 1 OUTLOOK AS PER ANNUAL RESULTS SHREY VIRANNA GROUP CEO 2 2018 Outlook FY Results Southern

More information

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION J.P. MORGAN HEALTHCARE CONFERENCE 10 JANUARY 2018 DANIE MEINTJES CEO MEDICLINIC INTERNATIONAL PLC MEDICLINIC RESULTS DISCLAIMER This presentation contains

More information

1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017

1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017 1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017 GROUP RESULTS 2 GROWTH IN PROFIT AND FCF Group Underlying 1 Reported 2 1H 2018 1H 2017 1H 2018 1H 2017 Revenue 856.5 808.7 856.5 808.7 EBIT 81.3 81.9 61.6 61.1

More information

4Q18 Results Presentation. 27 August 2018

4Q18 Results Presentation. 27 August 2018 4Q18 Results Presentation 27 August 2018 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given in

More information

Interim Results. Six months ended 31 August 2016

Interim Results. Six months ended 31 August 2016 Interim Results Six months ended 31 August 2016 Stefanutti Stocks City A multi-disciplinary construction group (Vision) (Mission) 2 www.stefanuttistocks.com y 2 Agenda Six month overview Operational Overview

More information

Spire Healthcare reports its results for the year ended 31 December 2017

Spire Healthcare reports its results for the year ended 31 December 2017 Spire Healthcare reports its results for the year ended 31 December 2017 London, UK, 2 March 2018, Spire Healthcare Group plc (LSE: SPI), one of the UK s leading independent hospital groups, today announces

More information

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015 U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday

More information

MTN Group Limited Results presentation for the six months ended 30 June 2017

MTN Group Limited Results presentation for the six months ended 30 June 2017 MTN Group Limited Results presentation for the six months ended 30 June 2017 Disclaimer The information contained in this document has not been verified independently. No representation or warranty express

More information

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015 Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare

More information

EMIS Group plc Full year results presentation 2017

EMIS Group plc Full year results presentation 2017 EMIS Group plc Full year results presentation 2017 Introduction Strong financial position with underlying growth despite one off costs Introduction Financial review Operational review Summary and outlook

More information

INTERIM FINANCIAL RESULTS

INTERIM FINANCIAL RESULTS Presentation Tuesday, 14 November 2017 INTERIM FINANCIAL RESULTS For the six months ended 30 September 2017 Contents EXECUTIVE OVERVIEW FINANCIAL REVIEW OPERATIONAL REVIEW OUTLOOK & STRATEGY Presented

More information

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015] U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position to Month 1 - April Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday

More information

GROUP RESULTS FY17 RESULTS

GROUP RESULTS FY17 RESULTS CLICK FY 2017 TO EDIT RESULTS MASTER TITLE YEAR ENDED 30 JUNE STYLE 2017 GROUP RESULTS 2 FINANCIAL HIGHLIGHTS Group Underlying 1 Reported FY 2017 FY 2016 FY 2017 FY 2016 Revenue 1,658.6 1,618.5 1,658.6

More information

FY2019 Interim results presentation

FY2019 Interim results presentation EXPLORE OUR WORLD Established 1975 I Listed JSE limited 1987 ADCORP IS A WORKPLACE SOLUTIONS COMPANY Presented by Innocent Dutiro Chief Executive Officer Cheryl Jane CJ Kujenga Chief Financial Officer

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

SIX MONTHS ENDED 30 SEPTEMBER 2018

SIX MONTHS ENDED 30 SEPTEMBER 2018 PRESENTATION TUESDAY, 20 NOVEMBER 2018 SIX MONTHS ENDED 30 SEPTEMBER 2018 CONTENTS PRESENTED BY Neil Birch Chief Executive Officer Harry Todd Chief Financial Officer 2 EXECUTIVE OVERVIEW 3 RESULTS SUMMARY

More information

CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE CUSIP: 18682W205

CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE CUSIP: 18682W205 CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE000134854 CUSIP: 18682W205 INTERIM CONDENSED CONSOLIDATED RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2017 Group turnover

More information

For personal use only

For personal use only Financial and Operational Review For the year ended 30 June 2017 Colin Goldschmidt CEO, Sonic Healthcare 16 August 2017 Forward-looking statements This presentation may include forward-looking statements

More information

Annual Results November 2015

Annual Results November 2015 Annual Results 2015 November 2015 Forward looking statements We may make statements that are not historical facts and relate to analyses and other information based on forecasts of future results and estimates

More information

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 1H18 results Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 Today s presenters Dr. Ian Kadish Managing Director and Chief Executive Officer Joined Integral Diagnostics in May 2017 Has held

More information

For personal use only

For personal use only Ramsay Health Care Limited MACQUARIE SECURITIES AUSTRALIA CONFERENCE 2015 6 May 2015 Christopher Rex, Managing Director AGENDA 1. Ramsay Health Care Overview 2. Group Financial Highlights for the six months

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

Board of Directors Finance Presentation 2015/16. Friday 25th September 2015

Board of Directors Finance Presentation 2015/16. Friday 25th September 2015 Board of Directors Finance Presentation 2015/16 Friday 25th September 2015 1. Summary of 2015/16 financial position This presentation is to update the Board in public of our latest financial position.

More information

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,

More information

Financial and Operational Review

Financial and Operational Review Financial and Operational Review For the year ended 30 June 2016 Colin Goldschmidt CEO, Sonic Healthcare 17 August 2016 Forward-looking statements This presentation may include forward-looking statements

More information

Colin Goldschmidt. Chief Executive Officer

Colin Goldschmidt. Chief Executive Officer Annual General Meeting 19 November 2009 Colin Goldschmidt Chief Executive Officer FY 2009 Highlights Record financial result Sonic outperforms guidance Business resilience in face of global financial crisis

More information

For personal use only

For personal use only ASX ANNOUNCEMENT 23 August 2012 RAMSAY HEALTH CARE REPORTS 14.5% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 up 14.5% to $252.6 million Reported statutory net profit after

More information

Appendix 4.1 MEETING: Haringey Clinical Commissioning Group Governing Body Meeting DATE: Thursday, 15 March 2018 TITLE: LEAD DIRECTOR: AUTHOR: CONTACT DETAILS: Operating Plan: Timetable and Governance

More information

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference June 7, 2017 Disclaimer Certain statements in this presentation and other oral or written statements made by the Company from time to time are may constitute forward-looking

More information

Adjusted earnings per share were 54.1p (2016: 58.8p). Statutory results. Underlying. growth

Adjusted earnings per share were 54.1p (2016: 58.8p). Statutory results. Underlying. growth 34 Pearson plc Annual report and accounts We expect ongoing headwinds in our US higher education courseware business to be offset by improving conditions in our other businesses. Coram Williams Chief Financial

More information

Earnings Presentation 2nd Quarter 2017

Earnings Presentation 2nd Quarter 2017 Earnings Presentation 2nd Quarter 2017 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section

More information

Hill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016

Hill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016 Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private

More information

PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST 2017

PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST CONTENTS 1 Commentary 2 Consolidated statement of comprehensive income Group turnover up 10.9% 3 Consolidated statement

More information

B e n e f i t O p t i o n s

B e n e f i t O p t i o n s 2018 Benefit Options 2018 What determines your decision to join a medical aid? At Selfmed we cut straight to the Is it the add-on s, you know the free gym membership and movie tickets or, is it the reliable

More information

YEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director

YEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director YEAR END RESULTS 31 MARCH 2018 Russell Down, Chief Executive Chris Morgan, Group Finance Director Customer service strategy improving performance Revenue (excluding disposals) 371.6m 6.4% FY17: 349.1m

More information

2018 FULL YEAR RESULTS PRESENTATION

2018 FULL YEAR RESULTS PRESENTATION 2018 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

Balance Sheet Benefis Health System For month Ended September

Balance Sheet Benefis Health System For month Ended September Montana Facility Finance Authority Hospital Revenue Series 2007 Bonds - $125 Million Benefis Health System Continuing Disclosure Quarterly Report (Quarter ended 9/30/2009) The accompanying unaudited balance

More information

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014 Integrated Quality, Performance and Finance Reporting Framework Reporting period: Month 9 December 2014 Contents Section Page Trust Scorecard 3 Trust Heatmap 5 Scorecard matrix 6 Areas of underperformance

More information

Presentation of consolidated results. For the 52 weeks ended 30 March 2013

Presentation of consolidated results. For the 52 weeks ended 30 March 2013 Presentation of consolidated results For the 52 weeks ended 30 March 2013 1 Agenda Strategic and operational update Financial review Looking forward Jürgen Schreiber CEO Mark Bower Deputy CEO & CFO Jürgen

More information

MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE

MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE MANAGEMENT S DISCUSSION OF FINANCIAL AND OPERATING PERFORMANCE Utilization Trends The Corporation has experienced an increase in utilization from the end of 2015 through fiscal year 2017. Occupancy of

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services September 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

2017 FULL YEAR RESULTS PRESENTATION

2017 FULL YEAR RESULTS PRESENTATION 2017 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

MEDICLINIC INTERNATIONAL PLC 2017/18 INTERIM RESULTS AND DECLARATION OF INTERIM CASH DIVIDEND

MEDICLINIC INTERNATIONAL PLC 2017/18 INTERIM RESULTS AND DECLARATION OF INTERIM CASH DIVIDEND Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 South

More information

Exhibit A EXAMPLE I: PERFORMANCE TARGETS. The Financial Target will affect 50% of the interest payable under the terms of the Bonds.

Exhibit A EXAMPLE I: PERFORMANCE TARGETS. The Financial Target will affect 50% of the interest payable under the terms of the Bonds. Exhibit A EXAMPLE I: PERFORMANCE TARGETS There will be a Financial Target and three Non-Financial Targets, as described below. The Financial Target will affect 50% of the interest payable under the terms

More information

Quarterly Strategy Note January 2017

Quarterly Strategy Note January 2017 Neil Brown & Richard Hasson Co-Heads Quarterly Strategy Note January 2017 THE SOUTH AFRICAN PRIVATE SECTOR HOSPITAL INDUSTRY AND ITS LISTED COMPANIES WILL THEY RECOVER OR IS IT TERMINAL? by Neil Brown

More information

Half year results 30 September 2017

Half year results 30 September 2017 Half year results 30 September November Russell Down, Chief Executive Chris Morgan, Group Finance Director Strong first half performance Revenue (excluding disposals) 183.2m 6.9% HY17: 171.4m EBITDA* 33.8m

More information

FY17 half-year results

FY17 half-year results FY17 half-year results For the period ended 31 December 2016 Robert Cooke Managing Director & Chief Executive Officer Michael Sammells Chief Financial Officer 22 February 2017 1 1HFY17 overview Financial

More information

Financial results presentation For the period ended 30 June External structural and cyclical impacts on results

Financial results presentation For the period ended 30 June External structural and cyclical impacts on results 212 Financial results presentation For the period ended 3 June 212 External structural and cyclical impacts on results Macro factor Developing versus developed world Consequence SA and Africa relatively

More information

2017/18 INTERIM RESULTS PRESENTATION

2017/18 INTERIM RESULTS PRESENTATION 2017/18 INTERIM RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

OVERVIEW Group highlights. The Maslow Hotel

OVERVIEW Group highlights. The Maslow Hotel OVERVIEW Group highlights The Maslow Hotel 2 Key indicators R5 407m R1 489m 334 cps 90 cps GROUP REVENUE GROUP EBITDA ADJ DILUTED HEPS DPS +4% (5%) (18%) (18%) 3 Kalahari Sands Operating environment Pressure

More information

IHH Healthcare reports Q profit of RM57.2 million

IHH Healthcare reports Q profit of RM57.2 million IHH Healthcare reports Q1 2018 profit of RM57.2 million Q1 HIGHLIGHTS: Sustained organic growth YoY: Higher revenue; EBITDA up on improved operational performance - Q1 2018 revenue up 6% year-on-year to

More information

FY 2017 Results Presentation. 6 December 2017

FY 2017 Results Presentation. 6 December 2017 FY 2017 Results Presentation 6 December 2017 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.

More information

Annual Results. 12 months ended 28 February Agenda

Annual Results. 12 months ended 28 February Agenda Annual Results 28 ruary 2015 Bridging y expectations Agenda 2015 2014 2 1 12 month overview Phase 1 of turnaround strategy successfully implemented Closed-out problem contracts Closed non-performing Power

More information

GUANGDONG KANGHUA HEALTHCARE CO., LTD.* (A joint stock company incorporated in the People s Republic of China with limited liability)

GUANGDONG KANGHUA HEALTHCARE CO., LTD.* (A joint stock company incorporated in the People s Republic of China with limited liability) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

J.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO

J.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations

More information

Case Study New Hospital Development : Project Management

Case Study New Hospital Development : Project Management SAFHE/CEASA 2017 The 12 th Biennial Conference and Exhibition Durban 7 9 March 2017 Case Study New Hospital Development : Project Management Presented by Keith Bonsall, Director Halcyon Management Services

More information

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 AGENDA Ramsay Financial Performance Pre Capio UK ( Ramsay UK ) Ramsay Financial Performance Including Ramsay UK Operational

More information

Results Presentation for the year ended 30 June 2012

Results Presentation for the year ended 30 June 2012 Results Presentation for the year ended 30 June 2012 Agenda Financial highlights Year at a glance Group at a glance Operational reviews Financial review Industrial Cable Suppliers Strategy and outlook

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY D REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018 Subject: NHS Planning Guidance 2018-19 Supporting TEG Member: Authors: Status Neil

More information

Fourth Quarter and Full Year 2018 Preliminary Results

Fourth Quarter and Full Year 2018 Preliminary Results Fourth Quarter and Full Year 2018 Preliminary Results www.ghg.com.ge Name of authorised official of issuer responsible for making notification: Ketevan Kalandarishvili, Head of Investor Relations 1 TABLE

More information

ADVANCED HEALTH LIMITED

ADVANCED HEALTH LIMITED ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) ( the Company or Advanced ) ISIN Code: ZAE000189049 JSE Code: AVL REVIEWED CONDENSED CONSOLIDATED

More information

OVERVIEW 1H17 RESULTS

OVERVIEW 1H17 RESULTS CLICK 1H 2017 TO EDIT RESULTS MASTER TITLE 6 MONTHS ENDED 31 STYLE DECEMBER 2016 OVERVIEW 2 FINANCIAL SUMMARY Group Underlying Reported 1H 2017 1H 2016 1H 2017 1H 2016 Revenue 808.7 794.3 808.7 814.1 EBIT

More information

Owensboro Health 4th Quarter (March May 2016) FY Ending May 31, 2016

Owensboro Health 4th Quarter (March May 2016) FY Ending May 31, 2016 Owensboro Health 4th Quarter (March May 2016) FY Ending May 31, 2016 Table of Contents Officer s Certificate of Compliance. 3 Management Discussion and Analysis.. 4 Utilization Statistics and Financial

More information

FINANCIAL RESULTS PRESENTATION H1FY18

FINANCIAL RESULTS PRESENTATION H1FY18 Virtus Health (ASX:VRT) FINANCIAL RESULTS PRESENTATION H1FY18 Tuesday 20 th February, 2018 9.15am AEDT DISCLAIMER The material in this presentation has been prepared by Virtus Health Limited ABN 80 129

More information

Regus Group plc Interim Report Six months ended June 2005

Regus Group plc Interim Report Six months ended June 2005 Regus Group plc Interim Report Six months ended June 2005 Financial Highlights (a) 216.0m TURNOVER (2004: 124.9m) 48.7m CENTRE CONTRIBUTION (2004: 17.5m) 22.3m ADJUSTED EBITA (b) (2004: 1.9m LOSS) 37.4m

More information

The Guthrie Clinic Financial Highlights for the Three and Six Months Ended December 31, 2017

The Guthrie Clinic Financial Highlights for the Three and Six Months Ended December 31, 2017 Financial Highlights for the Three and Six Months Ended December 31, 2017 I. Introduction In accordance with the provisions of the Master Indenture relating to the 2011 and 2007 Guthrie Health Bonds, enclosed

More information

The Independent Hospital Sector. Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008

The Independent Hospital Sector. Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008 The Independent Hospital Sector Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008 1 Agenda Overview of Ramsay Health Care The Independent Hospital Sector UK Market

More information

FY19 half year results

FY19 half year results FY19 half year results For the six months ended 31 December 2018 14 February 2019 Gordon Ballantyne Managing Director & Chief Executive Officer Michael Sammells Chief Financial Officer 1 1HFY19 returned

More information

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07)

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07) Original 0 0 0 ' s Var Kingston Hospital NHS Foundation Trust Finance Report October 2018 (Month 07) CONTENTS EXECUTIVE SUMMARY........3 SECTION 1: OVERALL INCOME AND EXPENDITURE.......4 SECTION 2: DIVISIONAL

More information